Hickey Benjamin
President, RayzeBio Org. at BMY; EVP, Chief Commercial Officer at Mirati Therapeutics, Inc.
- Sold, on record
- $1.8M
- Dollars the filings state
- Form 4 sales
- 11
- Latest May 9, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- BMYBRISTOL MYERS SQUIBB COPresident, RayzeBio Org.
- Mirati Therapeutics, Inc.EVP, Chief Commercial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Mirati Therapeutics, Inc.19,847 shares
- BMY97 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Mirati Therapeutics, Inc.Plan not statedJan 18 2022
Sold 627 shares at $120.48 ($76k)
Hickey Benjamin, EVP, Chief Commercial Officer
Sold 1.8% of holdings ($4.3M position)34,976 shares left0.3x usual sizeFiling
- 2 Form 4 sale Mirati Therapeutics, Inc.Plan not statedDec 21 +337 days
Sold 3,248 shares at $40.41 ($131k)
Hickey Benjamin, EVP, Chief Commercial Officer
Sold 6% of holdings ($2.2M position)50,877 shares left1.6x usual sizeFiling
- 3 Form 4 sale Mirati Therapeutics, Inc.Plan not statedJan 9 +19 days
Sold 2,088 shares at $45.37 ($95k)
Hickey Benjamin, EVP, Chief Commercial Officer
Sold 4.1% of holdings ($2.3M position)48,789 shares left1x usual sizeFiling
- 4 Form 4 sale Mirati Therapeutics, Inc.Plan not statedJan 17 +8 days
Sold 1,566 shares at $42.38 ($66k)
Hickey Benjamin, EVP, Chief Commercial Officer
Sold 3.2% of holdings ($2.1M position)47,223 shares left0.8x usual sizeFiling
- 5 Form 4 sale Mirati Therapeutics, Inc.No planDec 13 +330 days
Sold 2,220 shares at $56.67 ($126k)
Hickey Benjamin, EVP, Chief Commercial Officer
No 10b5-1 planSold 2.1% of holdings ($6M position)103,694 shares left1.1x usual sizeFiling
- 6 Form 4 sale Mirati Therapeutics, Inc.No planJan 8 +26 days
Sold 2,090 shares at $58.92 ($123k)
Hickey Benjamin, EVP, Chief Commercial Officer
No 10b5-1 planSold 1.7% of holdings ($7.1M position)118,625 shares left1x usual sizeFiling
- 7 Form 4 sale Mirati Therapeutics, Inc.No planJan 16 +8 days
Sold 1,597 shares at $59.02 ($94k)
Hickey Benjamin, EVP, Chief Commercial Officer
No 10b5-1 planSold 1.3% of holdings ($7M position)117,028 shares left0.8x usual sizeFiling
- 8 Form 4 sale BMYUnusualMay 9 +479 days
Sold 97 shares at $38.01 ($4k)
Hickey Benjamin, President, RayzeBio Org.
No 10b5-1 planSold 100% of holdings ($4k position)0 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (11)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 9, 2025 | BMY | President, RayzeBio Org. | Form 4 sale | 97 | $4k | 100.0% | Unusual | SEC |
| Jan 16, 2024 | Mirati Therapeutics, Inc. | EVP, Chief Commercial Officer | Form 4 sale | 1,597 | $94k | 1.3% | No plan | SEC |
| Jan 8, 2024 | Mirati Therapeutics, Inc. | EVP, Chief Commercial Officer | Form 4 sale | 2,090 | $123k | 1.7% | No plan | SEC |
| Dec 13, 2023 | Mirati Therapeutics, Inc. | EVP, Chief Commercial Officer | Form 4 sale | 2,220 | $126k | 2.1% | No plan | SEC |
| Jan 17, 2023 | Mirati Therapeutics, Inc. | EVP, Chief Commercial Officer | Form 4 sale | 1,566 | $66k | 3.2% | Plan not stated | SEC |
| Jan 9, 2023 | Mirati Therapeutics, Inc. | EVP, Chief Commercial Officer | Form 4 sale | 2,088 | $95k | 4.1% | Plan not stated | SEC |
| Dec 21, 2022 | Mirati Therapeutics, Inc. | EVP, Chief Commercial Officer | Form 4 sale | 3,248 | $131k | 6.0% | Plan not stated | SEC |
| Jan 18, 2022 | Mirati Therapeutics, Inc. | EVP, Chief Commercial Officer | Form 4 sale | 627 | $76k | 1.8% | Plan not stated | SEC |
| Jan 7, 2022 | Mirati Therapeutics, Inc. | EVP, Chief Commercial Officer | Form 4 sale | 1,964 | $267k | 7.3% | Plan not stated | SEC |
| Mar 19, 2021 | Mirati Therapeutics, Inc. | EVP, Chief Commercial Officer | Form 4 sale | 2,369 | $418k | 8.1% | Plan not stated | SEC |
| Jan 7, 2021 | Mirati Therapeutics, Inc. | EVP, Chief Commercial Officer | Form 4 sale | 2,078 | $450k | 9.5% | Plan not stated | SEC |